Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences
https://doi.org/10.21292/2075-1230-2022-100-9-59-64
Abstract
In the regions with the high prevalence of HIV infection, it is necessary to perform differential diagnosis of lung injury caused by COVID-19 and pneumocystis pneumonia.
The main complaints in COVID-19 and pneumocystis pneumonia are similar and include dyspnea, weakness, cough, fever, and ground glass radiographic syndrome. However, sputum production was more common in pneumocystis pneumonia. The most important differences were frequent anosmia in COVID-19 and its absence in pneumocystis pneumonia, frequent detection of oropharyngeal candidiasis in pneumocystis pneumonia which was not seen in COVID-19.
Serum hepcidin concentration has a high diagnostic potential and indicates a greater likelihood of COVID-19 than pneumocystis pneumonia at values ≤ 768.044 pg/ml (ROC AUC 0.977; p < 0.001).
About the Authors
E. A. Borodulina
Samara State Medical University
Russian Federation
Russian Federation
Elena A. Borodulina, Doctor of Medical Sciences, Professor, Head of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, 443099
Phone: +7 (846) 374-10-04 (ext. 4763)
E. S. Vdoushkina
Samara State Medical University
Russian Federation
Russian Federation
Elizaveta S. Vdoushkina, Candidate of Medical Sciences, Associate Professor of Phthisiology and Pulmonology Department
48, Pionerskaya St., Samara, 443099
Phone: +7 (846) 374-10-04 (ext. 4763)
E. V. Yakovleva
Samara State Medical University
Russian Federation
Russian Federation
Elena V. Yakovleva, Post-graduate Student of Phthisiatry and Pulmonology Department
48, Pionerskaya St., Samara, 443099
Phone: +7 (846) 374-10-04 (ext. 4763).
References
1. Averyanov A.V., Sotnikova A.G., Lesnyak V.N. Pneumocystis pneumonia mimicking COVID-19. Klinicheskaya Praktika, 2020, vol. 11, no. 2, pp. 87-92. (In Russ.)
2. Borodulina E.A., Yakovleva E.V., Povalyaeva L.V., Vdoushkina E.S., Sukhanova A.E. Comparative study of the serum hepcidin level of patients with pneumonia in COVID-19 and pneumocystis pneumonia. Klinicheskaya Laboratornaya Diagnostika, 2021, vol. 66, no. 11, pp. 645-649. (In Russ.) doi: https://dx.doi.org/10.51620/0869-2084-2021-66-11-645-649.
3. Viktorova I.B., Zimina V.N., Degtyareva S.Yu., Kravchenko A.V. Respiratory diseases in HIV-infected patients (review). Journal Infektologii, 2020, vol. 12, no. 4, pp. 5-18. (In Russ.) doi: 10.22625/2072-6732-2020-12-4-5-18.
4. Kozlov V.A., Tikhonova E.P., Savchenko A.A., Kudryavtsev I.V., Andronova N.V., Anisimova E.N., Golovkin A.S., Demina D.V., Zdzitovetsky D.E., Kalinina Yu.S., Kasparov E.V., Kozlov I.G., Korsunskiy I.A., Kudlay D.A., Kuzmina T Yu., Minoranskaya N.S., Prodeus A.P., Starikova E.A., Cherdantsev D.V., Chesnokov A.B., Shesternya P.A., Borisov A.G. Klinicheskaya immunologiya. Prakticheskoye posobiye dlya infektsionistov. [Clinical immunology. A practical guide for infectious disease specialists]. Krasnoyarsk, Polikor Publ., 2021, 563 p.
5. Akiyama Y. et al. Non-COVID-19 patients with life-threatening diseases who visited a fever clinic: a single-center, observational study in Tokyo, Japan. Intern. Med., 2020, vol. 59, no. 24, pp. 3131-3133. doi: 10.2169/internalmedicine.5614-20.
6. Coleman J.J., Manavi K., Marson E.J. et al. COVID-19: to be or not to be; that is the diagnostic question. Postgrad Med., J., 2020, vol. 96, no. 1137, pp. 392-398. doi:10.1136/postgradmedj-2020-137979.
7. Fujii T., Nakamura T., Iwamoto A. Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features. J. Infect. Chemotherapy, 2007, vol. 13, no. 1, pp. 1-7. doi: 10.1007/s10156-006-0484-5.
8. Hanfi S.H., Lalani T.K., Saghir A., McIntosh L.J., Lo H.S., Kotecha H.M. COVID-19 and its mimics: what the radiologist needs to know. J. Thorac. Imaging, 2021, vol. 36, no. 1, pp. W1-W10. doi: 10.1097/RTI.0000000000000554.
9. Hochhegger B., Zanon M., Altmayer S., Mandelli N.S., Stüker G., Mohammed T.L. et al. COVID-19 mimics on chest CT: a pictorial review and radiologic guide. Br. J. Radiol., 2021, vol. 94, no. 1118, pp. 20200703. doi: 10.1259/bjr.20200703. Epub 2020 Dec 9.
10. Salehi S., Abedi A., Balakrishnan S., Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. Am. J. Roentgenol., 2020, vol. 215, no. 1, pp. 87-93. doi: 10.2214/AJR.20.23034.
11. Yehouenou T., Onka B., El Bakkari A., Jerguigue H., Latib R., Omor Y. An etiology of ground ‒ glass images during COVID-19: Pneumocystis jirovecipneumonia. Open Med. Case Rep., 2022, Apr 14, 10:2050313X221091391. doi: 10.1177/2050313X221091391. eCollection 2022.PMID: 35449529.
12. Zhao W., Zhong Z., Xie X., Yu Q., Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia:a multicenter study. Am. J. Roentgenol., 2020, vol. 214, no. 5, pp. 1072–1077. doi: 10.2214/AJR.20.22976.
13. Zhou C., Chen Y., Ji Y., He X., Xue D. Increased serum levels of hepcidin and ferritin are associated with severity of COVID-19. Med. Sci. Monit., 2020, Sep 26. no. 26, pp. e926178. doi: 10.12659/MSM.926178.
Review
For citations:
Borodulina E.A., Vdoushkina E.S., Yakovleva E.V. Lung Injury in COVID-19 and Pneumocystis Pneumonia. Similarities and Differences. Tuberculosis and Lung Diseases. 2022;100(9):59-64. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-9-59-64
Views:
665
Email this article 